Literature DB >> 10688986

Effects of nitric oxide-modulating amino acids on coronary vessels: relevance to sepsis.

J A Mitchell1, P Gray, P D Anning, M Woods, T D Warner, T W Evans.   

Abstract

Excessive nitric oxide (NO) production in septic shock is thought to contribute to the associated profound hypotension. Here we show that despite induction of NO synthase (NOS) in the hearts of endotoxin-treated rats, coronary vascular responses to the contractile peptide endothelin-1, were not modified. This was not due to any change in the expression of endothelin receptors. However, when the substrate for NOS, L-arginine, was added to the perfusate, increases in coronary perfusion pressure stimulated by endothelin were reduced in hearts from endotoxin-treated animals compared to those from controls. In addition, L-glutamine, which blocks the generation of L-arginine from intracellular stores, enhanced the increase in perfusion pressure stimulated by endothelin-1. These data suggest that L-arginine becomes rate limiting for the production of NO in the coronary vessels during septic shock. Moreover, it suggests that vascular reactivity may be modulated positively or negatively by supplementation with the relevant amino acids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688986     DOI: 10.1016/s0014-2999(99)00837-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis.

Authors:  G Wu; T E Haynes; H Li; W Yan; C J Meininger
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  TNF-alpha and IL-1beta increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes.

Authors:  David J Duncan; Zhaokang Yang; Philip M Hopkins; Derek S Steele; Simon M Harrison
Journal:  Cell Calcium       Date:  2010-03-12       Impact factor: 6.817

3.  Development of a novel UHPLC-MS/MS-based platform to quantify amines, amino acids and methylarginines for applications in human disease phenotyping.

Authors:  Blerina Ahmetaj-Shala; Michael Olanipekun; Abel Tesfai; Niall MacCallum; Nicholas S Kirkby; Gregory J Quinlan; Chih-Chin Shih; Ryota Kawai; Sharon Mumby; Mark Paul-Clark; Elizabeth J Want; Jane A Mitchell
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.